Stay updated with breaking news from Treatment Acceleration Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "2021 Medical Devices Research Review" report has been added to ResearchAndMarkets.com's offering. The global contract manufacturing of...
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
Press release content from Business Wire. The AP news staff was not involved in its creation. Worldwide COVID-19 Diagnostics and Kits Industry to 2025 - by Product Type, Testing Type, End-user and Region - ResearchAndMarkets.com April 29, 2021 GMT DUBLIN--(BUSINESS WIRE)--Apr 29, 2021-- This report examines the current and future market potential of COVID-19 diagnostics. It offers an analysis of the competitive environment, regulatory scenario, technologies, and the drivers and restraints in the market’s growth. The report also covers market projections to 2025 and market rankings for key p...
The US Food and Drug Administration (FDA) has approved Investigational New Drug (IND) application submitted by Airway Therapeutics to develop AT-100 (rhSP-D) for treating patients with Covid-19.
To embed, copy and paste the code into your website or blog: Under President Joe Biden, pharmaceutical regulation may see increased FDA guidance, new strategies to speed up innovation and regulatory review, and a renewed focus on diseases with unmet needs, among other expectations. With President Joe Biden sworn in as the 46th US president, attention has turned to what actions he will take in his first 100 days in office, and beyond. While much of the president’s focus will initially be on the COVID-19 pandemic, increasing vaccination numbers, and economic relief, the pharmaceutical and bio...